PRFX logo

PRF TECHNOLOGIES LTD

PRFXNASDAQ
🏆 #5274 by market capUS Equity
$0.97▼ $0.00 (−0.02%)
Live
🔔
Track PRFX
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 0.0%
7d▲ 1.5%
14d▲ 6.8%
30d▼ 5.2%
ytd▼ 69.7%
1y▼ 85.7%
🏦Market Cap
$3M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
56
Weak

Trading Snapshot

Day Range
$0.97 – $0.99
52-Week Range
$0.85 – $7.95
Volume
$4.26B
Avg Volume
$5.04B
Shares Outstanding
3.0M
Next Earnings
Nov 18, 2026

Fundamentals Snapshot

Annual Revenue
$378,753
Last Q Revenue
$93,456
P/E Ratio
—
P/S Ratio
—
EPS (TTM)
$-9.71
Dividend Yield
—
Dilution (1yr)
+1000.9%

Why Investors Own PRFX

  • ✓High-growth profile — revenue up +53.9% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 52% gross margin and 8% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

PRFX logo

PRF TECHNOLOGIES LTD

PRFX
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$17K▲ +0.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-4864.7%▼ −5992.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$5M▼ −66.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$4M▼ −68.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
648K▲ +1000.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$3M▼ −$1M YoY
StockOtter · stockotter.space

About PRF TECHNOLOGIES LTD

PRF Technologies Ltd. operates as a specialized pharmaceutical company, currently in the clinical development stage, with a focus on pioneering treatments that deliver sustained post-surgical pain management. Central to its pipeline is PRF-110, a distinctive clear, viscous, oil-based solution. This innovative product is engineered for direct application into surgical incisions, aiming to provide targeted and prolonged alleviation of discomfort following operations. PRF-110 is presently undergoing assessment in two pivotal Phase 3 clinical trials, specifically for individuals recovering from bunionectomy and hernia repair procedures. The company, which was originally incorporated in 2007 under the name PainReform Ltd., maintains its headquarters in Tel Aviv, Israel.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
56/100

Analyst Price Target

ⓘ
Average Target
$1.26
▲ +29.8% Upside
High Target$1.42
Low Target$1.15
Based on 22 analysts

Latest News & Updates

🚀
CNBC·2h ago

PRF TECHNOLOGIES LTD tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Barron’s·5h ago

Analysts lift PRFX price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Bloomberg·1d ago

PRF TECHNOLOGIES LTD announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.